Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)
Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus
The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets
A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases
Promega automated sample preparation solution added to CDC COVID-19 test protocol
The test is intended to expand availability of COVID-19 screening resources in central Ohio
xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing
Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases
Partnership to evaluate the use of Affimer reagents to detect the coronavirus using novel sensors
Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine
The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand
Starts Monday, July 6. Register for free today to stay informed on the latest techniques and technologies for COVID-19 and infectious disease research
Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management
The platform aims to deliver rapid and automated processing of human blood and blood products to obtain purified populations of immune cells
binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
The partnership aims to provide accessible solutions for labs involved in COVID-19 testing
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
